Our Products

新藥產品

T-1101

First-in-Class Oral Dosage Hec1/Nek2 Inhibitor

T-1201

Novel Targeting Small Molecule-drug Conjugate (SN-38)

T-1301

Novel Multi-targeted Tyrosine Kinase Inhibitor (TKI)

Pipeline 

研發進度

Scroll to Top